Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 1651 AL 1665

A role for RNA knots in Alzheimer's disease

Galli S, Di Antonio M.

Elife. 2025 Feb 28;14:e106119. doi: 10.7554/eLife.106119.

Recent advances in the detection and management of motor dysfunction in Alzheimer's disease

Marogianni C, Siokas V, Dardiotis E.

Psychiatriki. 2025 Jul 2;36(2):97-100. doi: 10.22365/jpsych.2025.012. Epub 2025 May 14.

Utility of Harmonisation for Fixel-Based Metrics in Travelling Subjects and Alzheimer's Disease Data

Zou R, Kamagata K, Mito R, Takabayashi K, Andica C, Uchida W, Guo S, Kitagawa T, Fujita S, Uematsu A, Maikusa N, Koike S, Aoki S; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2025 Nov;46(16):e70408. doi: 10.1002/hbm.70408.

Brain topology alteration in Alzheimer's disease brain networks: A multi-center study

Ma L, Wang P, Wang D, Yao H, Zhou B, Zhao Y, Liao Z, Chen Y, Zhang X, Han Y, Lu J, Zhao K, Zhang Y, Liu Y; Alzheimer’s Disease Neuroimaging Initiative, for the Multi-Center Alzheimer’s Disease Imaging (MCADI) Consortium.

Neuroimage Clin. 2026;49:103919. doi: 10.1016/j.nicl.2025.103919. Epub 2025 Nov 30.

Patient eligibility for amyloid-targeting immunotherapies in Alzheimer's disease

Rosen J, Jessen F.

J Prev Alzheimers Dis. 2025 Apr;12(4):100102. doi: 10.1016/j.tjpad.2025.100102. Epub 2025 Feb 25.

A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's disease

Venkatraghavan V, Archetti D, Bourgeat P, Jiang C, Ten Kate M, van Loenhoud AC, Ossenkoppele R, Teunissen CE, van de Giessen E, Pijnenburg YAL, Frisoni GB, Weiss B, Vidnyánszky Z, Auer T, Durrleman S, Redolfi A, Laws SM, Maruff P, Oxtoby NP, Altmann A, Alexander DC, van der Flier WM, Barkhof F, Tijms BM; Australian Imaging Biomarkers and Lifestyle Study, for the Alzheimer’s Disease Neuroimaging Initiative, for the E-DADS Consortium.

Neuroimage. 2025 Sep;318:121381. doi: 10.1016/j.neuroimage.2025.121381. Epub 2025 Jul 20.

Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease

de Bruin H, Groot C, Barthel H, Bischof GN, Blazhenets G, Boellaard R, Boon BDC, Brendel M, Cash DM, Coath W, Day GS, Dickerson BC, Doering E, Drzezga A, van Dyck CH, van Eimeren T, van der Flier WM, Fredericks CA, Fryer TD, van de Giessen E, Gordon BA, Graff-Radford J, Grinberg LT, Hansson O, Hobbs DA, Hoenig MC, Höglinger G, Irwin DJ, Jones PS, Josephs KA, Katsumi Y, La Joie R, Lee EB, Levin J, Malpetti M, McGinnis SM, Mecca AP, Mohanty R, Nasrallah IM, O'Brien JT, O'Dell RS, Palleis C, Perneczky R, Phillips JS, Putcha D, Rabinovici GD, Rahmouni N, Rosa-Neto P, Rowe JB, Rullmann M, Sabri O, Saur D, Schildan A, Schott JM, Schroeter ML, Seeley WW, Servaes S, Sintini I, Smith R, Spina S, Stevenson J, Stomrud E, Strandberg O, Therriault J, Tideman P, Touroutoglou A, Trainer AE, Visser D, Wekselman F, Weston PSJ, Whitwell JL, Wolk DA, Yong K, Pijnenburg YAL, Franzmeier N, Ossenkoppele R.

Brain. 2025 Nov 4;148(11):3893-3912. doi: 10.1093/brain/awaf279.

Immunogenicity of a recombinant subunit COVID-19 vaccine: A prospective, multi-centre, longitudinal study in Chinese Alzheimer's disease patients

Weng Y, Huang Y, Zhang J, Wu Y, He Q, Litchev S, Wu A, Ling Z, Zhao L, Liao R, Shao L, Wang M, Xu Y, Gong R, Zhang Z, Wang Y, Wu TT, Lu S, Kong Q, Lv H.

Hum Vaccin Immunother. 2025 Dec;21(1):2591504. doi: 10.1080/21645515.2025.2591504. Epub 2025 Dec 3.

Assessing brain vascular impairment, white matter lesions and ApoE status as predictors of behavioral and psychological symptoms of dementia (BPSD) in a multicentre sample of patients with Alzheimer's disease: a multidisciplinary retrospective study

Vaianella L, Bove R, Giuliani A, Pavino V, Guglielmi V, Giacomini G, Rossi C, Massimetti MC, Iani C, Bizzarro A.

Ann Ist Super Sanita. 2025 Jan-Mar;61(1):42-49. doi: 10.4415/ANN_25_01_06.

A Preliminary Study on an Intelligent Segmentation and Classification Model for Amygdala-Hippocampus MRI Images in Alzheimer's Disease

Liu S, Zhou K, Geng D.

Acad Radiol. 2025 Dec;32(12):7459-7470. doi: 10.1016/j.acra.2025.08.039. Epub 2025 Sep 2.

Tolerability of rivastigmine transdermal patch in patients with Alzheimer's disease: a narrative review

García Ribas G, Ferrer-Picón E.

Expert Opin Drug Saf. 2026 Apr;25(4):643-655. doi: 10.1080/14740338.2025.2576520. Epub 2025 Oct 31.

Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer's disease: A pilot study

Guo R, Li D, Li F, Ji L, Liu H, Qiao H, Lv Z, Tang Y, Wang D.

J Alzheimers Dis. 2025 Mar;104(1):52-60. doi: 10.1177/13872877251313819. Epub 2025 Feb 5.

Meta-Analysis of Transcriptomic Studies of Blood and Six Brain Regions Identifies a Consensus of 15 Cross-Tissue Mechanisms in Alzheimer's Disease and Suggests an Origin of Cross-Study Heterogeneity

Hou J, Hess JL, Zhang C, van Rooij JGJ, Hearn GC, Fan CC, Faraone SV, Fennema-Notestine C, Lin SJ, Escott-Price V, Seshadri S; Alzheimer's Disease Neuroimaging Initiative; Holmans P, Tsuang MT, Kremen WS, Gaiteri C, Glatt SJ.

Am J Med Genet B Neuropsychiatr Genet. 2025 Jun;198(4):e33019. doi: 10.1002/ajmg.b.33019. Epub 2024 Dec 16.

Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023

Anschuetz A, Schwab K, Harrington CR, Wischik CM, Riedel G.

J Alzheimers Dis. 2025 Sep;107(2):452-476. doi: 10.1177/13872877251362212. Epub 2025 Sep 1.

VEGFB is a potential therapeutic target for Alzheimer's disease: Insights from integrative multi-omics analysis

Ye H, Zhuang C, Jin Z, Hu Y, He J, Yu Q, Hu H, Zheng Y.

J Alzheimers Dis. 2025 Dec;108(3):1073-1087. doi: 10.1177/13872877251385244. Epub 2025 Oct 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias